PRODUCT MONOGRAPH - Sanofi
Page 1 of 37 . PRODUCT MONOGRAPH . PrIMOVANE® (zopiclone) Tablets, 5.0 mg and 7.5 mg . Hypnotic and Sedative. sanofi-aventis Canada Inc. 2905 Place Louis R.-Renaud
Product, Monographs, Natives, Sanofi, Product monograph, Sanofi aventis
Download PRODUCT MONOGRAPH - Sanofi
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
Lantus SOLOSTAR - Sanofi
products.sanofi.caPage 1 LANTUS ® SOLOSTAR ® Instruction Leaflet . SoloSTAR ® is a prefilled pen for the injection of insulin. Your health professional has decided that SoloSTAR is appropriate for you, based on your ability to handle SoloSTAR.
PRODUCT MONOGRAPH - Sanofi
products.sanofi.caPLAVIX Product Monograph Page 1 of 55 . PRODUCT MONOGRAPH . PrPLAVIX®. Clopidogrel Tablets, Manufacturer’s Standard . 75 …
Kayexalate (sodium polystyrene sulfonate) - Sanofi
products.sanofi.caKAYEXALATE (sodium polystyrene sulfonate) is a cream or light brown fine powder of sodium polystyrene sulfonate. KAYEXALATE is a cation-exchange resin prepared in the
Thymoglobulin (anti-thymocyte globulin [rabbit]) - …
products.sanofi.caLive vaccines should not be administered to patients about to receive, receiving, or after treatment with Thymoglobulin. Concomitant administration of Thymoglobulin with live virus
PRODUCT MONOGRAPH - Sanofi
products.sanofi.caCLOLAR® (clofarabine for injection) Page 1 of 41. PRODUCT MONOGRAPH . PrCLOLAR®. Clofarabine for injection . 1 mg/mL (20 mg/20 mL) Antineoplastic Agent . sanofi-aventis Canada Inc. 2905 Place Louis-R.-Renaud
Product, Monographs, Sanofi, Product monograph, Product monograph sanofi
Myochrysine (sodium aurothiolamate) - Sanofi
products.sanofi.ca3 It is usually used for treating patients who show evidence of continued or additional disease activity despite conservative drug therapy, e.g. with salicylates or …
PRODUCT MONOGRAPH INCLUDING PATIENT …
products.sanofi.caADLYXINE - Product Monograph Page 1 of 79. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . Pr ADLYXINE™ . lixisenatide injection . 0.05 mg per mL (10 μg/dose)
Information, Product, Patients, Monographs, Medication, Including, Product monograph, Product monograph including patient, Including patient medication information
PRODUCT MONOGRAPH INCLUDING PATIENT …
products.sanofi.caPage 1 of 64. PRODUCT MONOGRAPH. INCLUDING PATIENT MEDICATION INFORMATION . PrPRALUENT®. alirocumab . solution for subcutaneous injection . 75 mg/mL and 150 mg/mL
Information, Product, Patients, Monographs, Medication, Including, Product monograph, Product monograph including patient, Including patient medication information
Renvela (sevelamer carbonate) - Sanofi
products.sanofi.caRenvela (sevelamer carbonate) Product Monograph Page 1 of 21. PRODUCT MONOGRAPH . PrRENVELA®. sevelamer carbonate tablets . 800 mg . Phosphate Binder . ATC code: VO3A EO2
PRODUCT MONOGRAPH LANTUS - Sanofi
products.sanofi.caPage 1 of 62 . PRODUCT MONOGRAPH . LANTUS®. Insulin glargine injection (rDNA origin) Solution for injection 100 U/mL . ATC code: A10AE04 . Antidiabetic Agent
Product, Monographs, Product monograph, Lantus, Product monograph lantus
Related documents
Amaryl® M S.R. (Glimepiride & Metformin HCI) - …
pk.sanofi-aventis.comtherefore be considered. The highest recommended dose per day should be 8 mg of glimepiride and 2000 mg Of metformin. Daily doses Of glimepiride Of more than 6 mg are more effective only
Aprovel (irbesartan) - Sanofi - Sanofi-aventis, a ...
pk.sanofi-aventis.compotassium-containing salt substitutes, potassium-sparing medicines (such as certain diuretics) or lithium-containing medicines. As with …
Xatral (alfuzosin hydrochloride) - Sanofi
products.sanofi.caPage 1 of 42. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . PrXATRAL®. Alfuzosin Hydrochloride . Prolonged-Release Tablets . 10 mg . Pharmaceutical standard: Professed
HIGHLIGHTS OF PRESCRIBING INFORMATION ... - …
products.sanofi.usHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TOUJEO safely and effectively. See full prescribing information for TOUJEO®
TETRAXIM Sanofi-Pasteur - Modern Medicine
www.meppo.com–if your child suffers from convulsant or non-con-vulsant progressive encephalopathy (neurological disease), –if your child has experienced a strong reaction
SUMMARY OF PRODUCT CHARACTERISTICS ... - …
www.sanofi-aventis.co.ukSUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Clexane® Syringes 2 QUALITATIVE AND QUANTITATIVE COMPOSITION …
SUMMARY OF PRODUCT CHARACTERISTICS ... - …
www.sanofi-aventis.co.ukReference: 67128 2011-10-13 - DSPC - Datapharm SPC 0.1 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Eloxatin 5 mg/ml concentrate for solution for infusion
Product, Summary, Characteristics, Summary of product characteristics 1, Summary of product characteristics